Immunophenotype of Chronic Myeloid Leukemia Patients on Tyrosine Kinase Inhibitor Treatment at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia

Simple item page
dc.contributor.advisorAster Tsegaye
dc.contributor.authorAzebTarekegn
dc.date.accessioned2025-08-12T17:12:37Z
dc.date.available2025-08-12T17:12:37Z
dc.date.issued2023-01-16
dc.description.abstractChronic myeloid leukemia (CML) is a cancer affecting blood forming cells in the bone marrow and blood. It is linked with an abnormal chromosome referred to as Philadelphia (Ph) chromosome, which occurs due to chromosomal translocation t (9; 22).
dc.identifier.urihttps://etd.aau.edu.et/handle/123456789/6367
dc.language.isoen_US
dc.publisherAddis ababa University
dc.subjectImmunophenotype
dc.subjectCML
dc.subjectFlowcytometry
dc.subjectTKI
dc.titleImmunophenotype of Chronic Myeloid Leukemia Patients on Tyrosine Kinase Inhibitor Treatment at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia
dc.typeThesis

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
AzebTarekegn.pdf
Size:
1.32 MB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description:
Download

Collections

Medical Laboratory Sciences